Prefilled Syringes Market Share, Size, Trends, Industry Analysis Report, By Material (Glass and Plastic); By Design (Dual Chamber, Single Chamber, and Customized); By Type (Conventional, and Safety Syringes); By Application (Insulin, Vaccine, Anti-coagulant, and Others), By Regions; Segment Forecast, 2020 –2027

Report Summary

The global prefilled syringes (PFS) market was valued at USD 4.72 billion in 2019 and is expected to grow at a CAGR of 9.8% during the forecast period. The significant factors propelling prefilled syringes market growth include increase in the prevalence of chronic and infectious diseases, consumer preference towards self administration, its benefits over the conventional syringes, and increasing usage in the non-medical settings. Most of the pharmaceutical companies are shifting their focus from traditional devices to PFS owing to their financial, economic, and logistic benefits. With a strong interest in the healthcare industry for PFS, owing to its convenience by the patients. Many of the latest and upcoming biotech and liquid stable formulation drugs cannot be self-administered with ease using traditional syringes.

行业动态

增长司机
制药工业从小分子化学药物到大分子，包括生物学的转化。生物制剂使得肿瘤和免疫学如肿瘤和免疫学等许多严重疾病的长期治疗进展。因此，许多制药公司正在投入更多的资源和研究生物制剂的研究。目前，10名发育中的六种药物是需要肠胃外给药的生物学。PFS是包装和提供生物产品的重要选择，因为其优点如材料和成本节约，准确性和易于管理。PFS中可用的10种药物中有九种药物是生物学，其中大部分用于治疗糖尿病，多发性硬化和类风湿性关节炎等慢性疾病。根据Phrma，目前，大约900个生物药物和100多种疾病的疫苗在临床试验中，大部分将使用PFS作为优选的递送系统和主要集装箱。

Know more about this report:请求样本页面

Challenges
PFS与许多限制和缺点相关联。由于药物与注射器的初级包装（活塞，喷嘴盖等）直接接触，用于在PFS中储存在PFS中，药物的质量受到损害。用于润滑PFS以确保最佳功能的硅油本身可以是设备中可提取或可浸出的源。许多制造的药物在它们中具有蛋白质和肽的含量，其可以与PFS的玻璃表面相互作用。PFS中的钨残留物也可以降低生物技术药物。有许多实例在PFS中提供药物的制药公司由于不利的互动而回忆起产品。

预填充注射器市场报告范围

该市场主要根据材料，按设计，按应用程序和地理区域进行分段。

By Material	By Design	按类型	By Application	By Region
Glass Plastic	Dual Chamber 单室 Customized	Conventional 安全	Insulin 疫苗 抗凝物 其他	·北美（美国，加拿大） · Europe (France, Germany, UK, Italy, Spain, Netherlands, Austria) · Asia Pacific (Japan, China, India, Malaysia, Indonesia. South Korea) ·拉丁美洲（巴西，墨西哥，阿根廷） ·MEA（沙特阿拉伯，阿联酋，以色列，南非）

Know more about this report:请求样本页面

材料洞察力

Based upon the material, the global prefilled syringe market is categorized into glass and plastic syringes. In 2019, the glass PFS accounted for the largest share in the global market, however, this dominance is challenged by the plastic PFSs, owing to its comparative better offerings and growing adoption among the physicians.

塑料具有更好的设计灵活性和尺寸精度的额外优点，当它们与自动喷射器或针安全系统等设备相结合时至关重要的PFS。制造商还可以使用鲁尔锁设计和整合塑料PFS，该锁锁优于玻璃PFS中使用的鲁尔锁定适配器。生物制药的数量以重大速度增加。这些是高度粘性的，需要对注射器法兰进行更多压力进行递送。玻璃PFS更容易发生在运动时较轻，而塑料PFS是鲁棒的，并且通过施加高力来促进生物学的递送。

Insight by Application

On the basis of application, the global market is categorized into insulin, vaccine, anti-coagulant, and others. In 2019, the insulin segment accounted for the largest share, followed by vaccine and anticoagulants segments. The rising incidence of diabetes in both developed and developing countries, increasing patient's preference for home healthcare, and increasing physician's preference for PFS due to accurate insulin delivery and increasing adherence to treatment regimens are driving the segment’s growth.

地理概述

Geographically, the global prefilled syringes market is bifurcated into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa (MEA). North America region is the largest revenue contributor followed by Europe and the Asia Pacific region. In 2019, the North America region accounted for more than 42% of the global market.

慢性疾病如糖尿病和疫苗可预防的传染病的患病率较高，推动了该地区预填充注射器市场的生长。几乎，美国人或美国每一个人的每一个人都有至少一种慢性疾病。2015年，近4430万人在北美和加勒比岛屿国家患有糖尿病，预计将达到60.5百万到2040年。PFS设备和CDC建议的技术进步是影响PFS增长的其他因素市场在美洲。乐动娱乐官网美国的医疗保健改革专注于减少最终用户的医疗保健支出。这些改革增加了在非医疗环境中使用自注装置。上述因素负责有关市场增长。

APAC是全球市场上增长最快的地区，中国成为主要的收入贡献者。人口上升，慢性疾病的患病率升高，可预防疾病和技术进步的疫苗正在推动市场的增长。据估计，世界上近50％的糖尿病患者生活在中国，印度，美国，巴西和印度尼西亚，为市场渗透提供了巨大的机会。这些地区的许多国家目前依靠发达国家的PFS进口。例如，通过来自美国，德国和法国等国家的进口，满足印度PFS的超过85％。然而，许多PFS制造商正在寻求将他们的业务扩展到印度和中国等新兴国家，以增加其业务。APAC的许多玩家正在增加其生产能力以满足PFS的需求。

Competitive Insight

在全球已经预装好的注射器有一个寡头垄断market where only few players are holding majority of market share. The prominent players operating in the market are Becton Dickinson (BD), Medpro, Haselmeier AG, Stevanato Group, Owen Mumford, SCHOTT, Unilife Corporation, OMPI, Fresenius Kabi, Catalent, Vetter Pharma International GmbH, Gerresheimer, Weigao Corporation, West Pharmaceutical Services, Inc., and Nipro Medical Corporation.

The intense rivalry is resulting in shifting the bargaining power from sellers to the buyers. Companies are focusing on acquisitions, partnerships, and technological advancements to expand in the market. The demand and supply gap in the market enabling the suppliers to revamp up production capabilities, while the existing players are focusing on expanding their production, new entrants are focusing on development of new and improved designs by using advanced materials such as COP-based plastic and advanced and innovative drug filling technologies.